# Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers

> **NCT01088932** · PHASE1 · COMPLETED · sponsor: **Azevan Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SRX246

## Key facts

- **NCT ID:** NCT01088932
- **Lead sponsor:** Azevan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2010-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01088932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01088932, "Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01088932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*